Skip to main navigation Skip to search Skip to main content

Phase I Study to Evaluate the Effect of Hepatic Impairment on Pharmacokinetics and Safety of Tegoprazan, a Potassium Competitive Acid Blocker

  • Anhye Kim
  • , Dongseong Shin
  • , Youlim Seo
  • , Deborah Kang
  • , Yang Won Min
  • , In Hee Kim
  • , Jungryul Kim*
    • *Corresponding author for this work
  • CHA University
  • CHA University School of Medicine
  • Gachon University
  • HK inno.N Corp
  • Samsung Medical Center, Sungkyunkwan university

Research output: Contribution to journal › Journal article › peer-review

1   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Phase I Study to Evaluate the Effect of Hepatic Impairment on Pharmacokinetics and Safety of Tegoprazan, a Potassium Competitive Acid Blocker'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science